RenalShield · Clinical Advocacy Portal

Anemia, Iron Metabolism & ESA Safety Suite

Track your hemoglobin trajectory, evaluate circulating iron (TSAT) versus storage iron (Ferritin), screen for functional iron deficiency, and protect against rapid hematocrit spikes or Erythropoiesis-Stimulating Agent (ESA) resistance based on KDIGO and KDOQI clinical guidelines.

Educational Consultation Tool: Maintaining Hemoglobin in the optimal 10.0–11.5 g/dL target window prevents severe fatigue while protecting against cardiovascular thrombosis and access clotting. This tool assists patients in preparing for monthly nephrology anemia reviews and does not prescribe or modify ESA doses or IV iron.

1-Click Clinical Case Presets

Enter Anemia & Iron Bloodwork

Target: 10.0 – 11.5 g/dL
For 30-day velocity (Δ)
Target: 20% – 50%
HD: 200–500 ng/mL
e.g. 2,000–10,000 Units